Literature DB >> 7537460

Immunochemical localization of type I VIP receptor and NK-1-type substance P receptor in rat lung.

S Ichikawa1, S P Sreedharan, R L Owen, E J Goetzl.   

Abstract

Peptidergic nerves in the respiratory tract release vasoactive intestinal peptide (VIP) and substance P (SP), which mediate physiological and immune functions. Antipeptide antibodies to type I VIP receptor (VIPR) and NK-1-type SP receptor (SPR) were used to identify these receptors in normal rat lungs. VIPRs and SPRs were detected on airway epithelium from the trachea to the respiratory bronchioles but not in alveoli, submucosal glands, or pulmonary smooth muscle, except for that of some pulmonary veins. VIPRs also were expressed on macrophages around capillaries, in tracheal and bronchial connective tissue, in alveolar walls, and in the subintima of pulmonary veins and some arterioles. The absence of receptors from airway smooth muscle and submucosal glands implies that mediation of some known effects of SP and VIP may be epithelial or macrophage dependent. Other types of VIPRs and SPRs on airway glands and smooth muscle may transduce direct effects. The similar localization of VIPRs and SPRs in rat lung suggests that VIP and SP may coordinately regulate some pulmonary functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537460     DOI: 10.1152/ajplung.1995.268.4.L584

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro.

Authors:  Y C Liu; A M Khawaja; D F Rogers
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

Authors:  E J Goetzl; J K Voice; S Shen; G Dorsam; Y Kong; K M West; C F Morrison; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

4.  Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.

Authors:  Renaud Dérand; Alicia Montoni; Laurence Bulteau-Pignoux; Thierry Janet; Bertrand Moreau; Jean-Marc Muller; Frédéric Becq
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

5.  PKCε stimulation of TRPV1 orchestrates carotid body responses to asthmakines.

Authors:  Nicholas G Jendzjowsky; Arijit Roy; Mircea Iftinca; Nicole O Barioni; Margaret M Kelly; Brittney A Herrington; Frank Visser; Christophe Altier; Richard J A Wilson
Journal:  J Physiol       Date:  2020-12-04       Impact factor: 5.182

6.  Resequencing and SNP discovery of Amur ide (Leuciscus waleckii) provides insights into local adaptations to extreme environments.

Authors:  Shuangyi Wang; Youyi Kuang; Liqun Liang; Bo Sun; Xuefei Zhao; Limin Zhang; Yumei Chang
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

Review 7.  Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.

Authors:  Jessica Lu; Sarah J Piper; Peishen Zhao; Laurence J Miller; Denise Wootten; Patrick M Sexton
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

8.  Inhaled corticosteroids inhibit substance P receptor expression in asthmatic rat airway smooth muscle cells.

Authors:  Miao Li; Yun-xiao Shang
Journal:  BMC Pulm Med       Date:  2012-12-17       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.